Mycorena Innovation and Development centre (MIND) has recently expanded its facilities in Gothenburg, to become Europe's largest demo production facility currently in full operation.
The newly expanded MIND facility in the heart of Gothenburg city centre, now hosts the company's office headquarters, a fully food-grade certified fermentation facility, Innovation and R&D labs, a development kitchen, and a pilot line for the production of end-consumer food products.
The current production facility at MIND is fully equipped with numerous custom designed fermenters ranging from benchtop to industrial demo-scale, capable of producing hundreds of tons of (annual) mycoprotein to be used as a food ingredient. The new facility is also equipped with state-of-the-art automation solutions making it one of the most unique fermentation scale-up facilities in Europe.
In addition to fermentation capacity, the fully modular and custom-built downstream processes are available for both the established Promyc® production process and also for the development of new variations of mycoprotein ingredients. Furthermore, the production process is fully food-graded and certified vegan, allergen-free, and kosher for the commercialization of ingredients and food products.
To pursue the company's core mission of creating futuristic innovations within the food industry using fungi-based technologies, MIND has established four different house labs for all its research and development efforts within fermentation, quality control and product development.
There is also a dedicated pilot-line production of end-consumer food products (made using mycoprotein), making MIND one of the few facilities globally to have an inclusive fermenter to fork approach production line. The pilot line is equipped to handle thousands of tons (annual) of mince-based vegan food products.
Swedish foodtech company Mycorena is a pioneer in the new age of mycoprotein fermentation and a proud enabler for the food industry to adopt mycoprotein as a versatile ingredient. MIND is a key factor in this equation, as the purpose of this facility is not only for the development of technologies and commercial processes but also to supply customers with the volumes needed to develop full food products in time for an accelerated commercial launch.
The company recently raised € 24M to fulfil its expansion plans and build one of the most significant upcoming commercial production sites for food mycoprotein, the Promyc Production Plant, situated less than one hour away from MIND.